Literature DB >> 28234598

Refractory social anxiety disorder.

Michael Van Ameringen1, Beth Patterson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28234598      PMCID： PMC5373715          DOI： 10.1503/jpn.160016

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  17 in total

Review 1.  Abuse Potential of Pregabalin: A Systematic Review.

Authors:  Ole Schjerning; Mary Rosenzweig; Anton Pottegård; Per Damkier; Jimmi Nielsen
Journal:  CNS Drugs       Date:  2016-01       Impact factor: 5.749

Review 2.  Obsessive-compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults.

Authors:  Naomi A Fineberg; Samar Reghunandanan; Helen B Simpson; Katharine A Phillips; Margaret A Richter; Keith Matthews; Dan J Stein; Jitender Sareen; Angus Brown; Debbie Sookman
Journal:  Psychiatry Res       Date:  2015-02-11       Impact factor: 3.222

3.  Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.

Authors:  Karl Rickels; Mark H Pollack; Douglas E Feltner; R Bruce Lydiard; Daniel L Zimbroff; Robert J Bielski; Kathy Tobias; Jerri D Brock; Gwen L Zornberg; Atul C Pande
Journal:  Arch Gen Psychiatry       Date:  2005-09

4.  A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder.

Authors:  Mark H Pollack; Michael Van Ameringen; Naomi M Simon; John W Worthington; Elizabeth A Hoge; Aparna Keshaviah; Murray B Stein
Journal:  Am J Psychiatry       Date:  2014-01       Impact factor: 18.112

5.  Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: randomised, double-blind, placebo-controlled, fixed-dose study.

Authors:  Malcolm Lader; Karina Stender; Vera Bürger; Rico Nil
Journal:  Depress Anxiety       Date:  2004       Impact factor: 6.505

Review 6.  Antiepileptic drugs in the treatment of anxiety disorders: role in therapy.

Authors:  Michael Van Ameringen; Catherine Mancini; Beth Pipe; Mark Bennett
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study.

Authors:  Atul C Pande; Douglas E Feltner; James W Jefferson; Jonathan R T Davidson; Mark Pollack; Murray B Stein; R Bruce Lydiard; Rïse Futterer; Paula Robinson; Mary Slomkowski; Eugene DuBoff; Mary Phelps; Carol A Janney; John L Werth
Journal:  J Clin Psychopharmacol       Date:  2004-04       Impact factor: 3.153

Review 8.  Social anxiety disorder.

Authors:  Murray B Stein; Dan J Stein
Journal:  Lancet       Date:  2008-03-29       Impact factor: 79.321

9.  Update on the efficacy of pharmacotherapy for social anxiety disorder: a meta-analysis.

Authors:  Michelle L Davis; Jasper A J Smits; Stefan G Hofmann
Journal:  Expert Opin Pharmacother       Date:  2014-10-05       Impact factor: 3.889

Review 10.  Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review.

Authors:  Mazda Adli; Christopher Baethge; Andreas Heinz; Nicolas Langlitz; Michael Bauer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-04-29       Impact factor: 5.760
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.